Siemens technology at the core of VISIUS iCT's state-of-the-art image
MINNEAPOLIS, Oct. 9, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") and Siemens Healthcare today announced that
the companies have strengthened their sales collaboration through a new
agreement that positions one of Siemens' most innovative computed
tomography (CT) products as the core of the IMRIS VISIUS® iCT solution.
"Siemens and IMRIS have successfully collaborated on solutions for
intraoperative magnetic resonance imaging and angiography, so adding CT
is a natural extension of this relationship," said Murat Gungor, Vice
President, CT and Radiation Oncology Business Unit, Siemens Healthcare
North America. "We are looking forward to bringing the established
benefits of low-dose CT imaging to the intraoperative environment."
Developed for the neurosurgery and spine surgery markets, the VISIUS iCT
has at its core the 64- slice Siemens SOMATOM® Definition AS scanner. IMRIS received U.S. Food and Drug Administration
(FDA) 510(k) clearance for VISIUS iCT in July. The company currently
has systems sold to three major eastern US neurosciences centers.
"Siemens has helped co-develop the VISIUS iCT from concept to
commercialization," said Jay D. Miller, IMRIS President and CEO. "We
are excited to coordinate our companies' sales efforts to bring these
solutions for intraoperative imaging to even more healthcare
The VISIUS iCT moves effortlessly into and out of the operating room in
less than 30 seconds using ceiling-mounted rails and features advanced
software applications that maximize image quality while minimizing
radiation exposure in real time and industry leading post-processing
software to enhance surgical diagnosis and intervention.
VISIUS iCT enables multiple operating room configurations to meet
clinical requirements and increase system utilization. Layouts include
one- or two- OR configurations with a center room isolating the CT from
the surgical theater while not in use.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 54 leading medical
institutions around the world.
SOURCE IMRIS Inc.